Cancer Screening Tests Included in Health Checkups

Why Private Checkups Include Cancer Biomarkers

NHS screening programmes are population-level tools – highly effective for the cancers they target. Private health checkups can complement NHS programmes by adding blood-based tumour markers that cover prostate, ovarian, liver, pancreatic and colorectal cancer risk indicators.

Importantly, no blood test can diagnose cancer by itself. Biomarkers are screening tools: they raise or lower suspicion, guide next steps and – when tracked over time – reveal trends that a single test may miss. For a broader look at the scope and limits of full-body checkups, see our article on whether a full-body checkup can detect all diseases.

For a deeper look at which tumour markers map to which cancers, see our guide to cancer risk screening tests that help early detection.

Blood Biomarkers Explained

The table below summarises the cancer-related biomarkers most commonly included in private health checkup packages in the UK.

Our article on the full blood count (FBC) test explains what each parameter within the FBC reveals.

Standard vs Advanced vs Platinum Packages

The number of cancer biomarkers included depends on the checkup tier:

For help choosing between tiers, see our guide to why cancer screening is crucial even if you feel perfectly healthy. You can also compare all package levels in our article on the difference between basic, advanced and platinum health checks.

How a Full Blood Count Supports Cancer Screening

The FBC is not a tumour marker, but it is a valuable indirect screening tool. Abnormalities such as unexplained anaemia, elevated white cell counts or abnormal platelet levels may warrant further investigation, as they can sometimes be associated with haematological conditions (such as leukaemia, lymphoma or myeloma) or with chronic blood loss.

Because it is included in every tier, the FBC acts as a safety net even in the most basic checkup. For a full breakdown, read our article on early warning signs of cancer and how regular screening can help.

What to Expect on the Day

1. Registration & health questionnaire: You complete a short form covering medical history, family history and current medications.
2. Vital signs: Blood pressure, heart rate, BMI, waist circumference.
3. Blood draw: A single venous sample (usually 3–5 tubes) covers all requested biomarkers. The draw takes under five minutes.
4. Optional extras: ECG, urinalysis or body-composition scan depending on your package.
5. Results consultation: A GMC-registered doctor reviews your results – typically within 24–72 hours – and discusses next steps.

For a broader overview of what a full screening appointment involves, see our guide to what happens during a full-body MOT.

Understanding Your Results

Every result is compared against laboratory reference ranges and interpreted in the context of your age, sex, medical history and other panel values. Key principles:

• Within range ≠ zero risk: Results within normal limits reduce but do not eliminate the possibility of underlying disease.
• Above range ≠ cancer: Most elevated tumour markers are caused by benign conditions. A raised result triggers further investigation, not a diagnosis.
• Trends matter: A marker that rises steadily over successive screens is more clinically significant than a single mildly elevated reading.

Your post-screening consultation is the most important part of the process – it translates numbers into actionable next steps. For more on interpreting laboratory values, see our guides to understanding reference ranges in blood tests and when abnormal results should trigger further tests.

Frequently Asked Questions